| MEDI | Monday, 11 September 2006 | ||
1:30 PM-4:50 PM Moscone Center -- Room 102, Oral | |||
Reverse Pharmacology: The Role of Medicinal Chemistry in Novel Target Identification | |||
| Organizer: | Larry Hamann | ||
| 1:30 PM | 273 | Discovery of viral primases as drug targets: Compound based target elucidation, validation, and advancement to the clinic Jay P. Powers, J. Adrian, X. Chen, T. D. Cushing, H. Dimaio, J. C. Jaen, L. Liang, V. Mayorga, S. Miao, M. G. Peterson, F. Spector, C. Stein, M. Wright, Q. Ye | |
| 2:10 PM | 274 | Stem cell differentiation and small molecule Hedgehog signaling modulators Xu Wu | |
| 2:50 PM | 275 | Discovery of agonists of the glucose dependent insulinotropic receptor, GPR119, a pancreatic beta-cell oGPCR, for the treatment of NIDDM Robert M. Jones | |
| 3:30 PM | 276 | Estrogen receptor-related receptors α and γ as targets for drug discovery William J. Zuercher, James M. Way, Andrew N. Billin, Aaron B. Miller, Lisa A. Orband-Miller, Robert T. Nolte, Liping Wang, Timothy M. Willson | |
| 4:10 PM | 277 | Finding targets for drugs: The chemical genetic approach John Tallarico | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
Symposium Grid -- Drug Discovery -- Session Listing
The 232nd ACS National Meeting, San Francisco, CA, September 10-14, 2006